Literature DB >> 2773968

Lyme disease concurrent with human immunodeficiency virus infection.

J C Garcia-Monco1, H M Frey, B F Villar, M G Golightly, J L Benach.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2773968     DOI： 10.1016/s0002-9343(89)80158-5

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  7 in total

1.  Lyme borreliosis: host responses to Borrelia burgdorferi.

Authors:  A Szczepanski; J L Benach
Journal:  Microbiol Rev       Date:  1991-03

2.  Lyme neuroborreliosis in a patient treated with TNF-alpha inhibitor.

Authors:  Maja Ivartnik Merkac; Janez Tomazic; Franc Strle
Journal:  Infection       Date:  2015-04-29       Impact factor: 3.553

Review 3.  Management of Lyme Disease in European Children: a Review for Practical Purpose.

Authors:  Matteo D'Alessandro; Anna Loy; Elio Castagnola
Journal:  Curr Infect Dis Rep       Date:  2017-08       Impact factor: 3.725

Review 4.  Severe course of Lyme neuroborreliosis in an HIV-1 positive patient; case report and review of the literature.

Authors:  Nathalie D van Burgel; Mayke Oosterloo; Frank P Kroon; Alje P van Dam
Journal:  BMC Neurol       Date:  2010-11-30       Impact factor: 2.474

5.  Lyme neuroborreliosis in HIV-1 positive men successfully treated with oral doxycycline: a case series and literature review.

Authors:  Daniel Bremell; Christer Säll; Magnus Gisslén; Lars Hagberg
Journal:  J Med Case Rep       Date:  2011-09-19

6.  Molecular identification of tick-borne pathogens in asymptomatic individuals with human immunodeficiency virus type 1 (HIV-1) infection: a retrospective study.

Authors:  Renata Welc-Falęciak; Justyna D Kowalska; Małgorzata Bednarska; Magdalena Szatan; Agnieszka Pawełczyk
Journal:  BMC Infect Dis       Date:  2018-05-18       Impact factor: 3.090

7.  Bilateral facial palsy as the first sign of HIV infection.

Authors:  Fabrizio Giammello; Chiara Vitale; Vincenzo Rizzo; Antonio Toscano; Paolo Girlanda
Journal:  Neurol Sci       Date:  2022-08-09       Impact factor: 3.830
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.